AzTrials
AzTrials

Inguinal HerniaNCT03640598

Erector Spinae Versus Ilioinguinal/ Ilio-hypogastric Block in Children Undergoing Inguinal Surgeries

A study testing Ilioinguinal/iliohypogastric nerve blocks and Erector spinae nerve block in people with Inguinal Hernia, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Investigators aim to compare the efficacy of US-guided II/IH nerve block versus US-guided ES block for pediatric unilateral inguinal hernia repair with respect to postoperative analgesia Read more about this study

Who is it for?
Ages 1 year to 10 years
Conditions the study is for
Inguinal Hernia
What is being tested?
Ilioinguinal/iliohypogastric nerve blocks and Erector spinae nerve block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
20 Aug 2018to 1 Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • : American Society of Anesthesiologists physical status I - II

Who cannot join

  • History of clinically significant cardiac disease.
  • History of clinically significant hepatic disease.
  • History of clinically significant renal disease.
  • History of clinically significant neurological disease.
  • Known allergy to local anaesthetics

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Enas A Abd el Motlb

    Al Mansurah, DK, 050

Other trials in Egypt

About this study

Official title: Ultrasound Guided Erector Spinae Versus Ilioinguinal/ Ilio-hypogastric Block for Postoperative Analgesia in Children Undergoing Inguinal Surgeries

Investigators aim to compare the efficacy of US-guided II/IH nerve block versus US-guided ES block for pediatric unilateral inguinal hernia repair with respect to postoperative analgesia

Read the detailed description

regarding patient registry; a prior G power analysis was done. 24 per group was determined to achieve 80% power to detect a difference of 60 min in time to first rescue analgesia between the two groups with a significance level (α) of 0.05 using a two-sided two-sample t-test; 25 patients were included per group to replace any dropouts.

  • Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social Sciences). Program version 22. Distribution of data will be first tested by the Shapiro test. Data will be presented as the mean and standard deviation (SD), median and range or numbers and percentages. For normally distributed data, the unpaired t-test will be used to compare the mean values of both groups. For pain score, Mann Whitney U test will be used. Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will be considered as the level of statistical significance.
Conditions
Inguinal Hernia
Being tested
Ilioinguinal/iliohypogastric nerve blocks, Erector spinae nerve block
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ilioinguinal/iliohypogastric nerve blocksProcedure or surgery

    The patient will receive ultrasound-guided Ilioinguinal/iliohypogastric nerve blocks with0.5 ml/kg 0.125 mg/kg bupivacaine + fentanyl 2ug/ml injectate

  • Erector spinae nerve blockProcedure or surgery

    The patient will receive ultrasound-guided erector spinae nerve block 0.5 ml/kg 0.125 bupivacaine + fentanyl 2ug/ml injectate.

Study groups in NCT03640598
Study groupRoleWhat they receive
Ilioinguinal/iliohypogastric nerve blocksOtherThe patient will receive ultrasound-guided Ilioinguinal/iliohypogastric nerve blocks
Receives: Procedure: Ilioinguinal/iliohypogastric nerve blocks
Erector spinae nerve blockOtherThe patient will receive ultrasound-guided erector spinae nerve block
Receives: Procedure: Erector spinae nerve block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative CHEOPS scale

    The scale includes six entries with an appropriate point evaluation focused on the character of crying (1-3 points), facial expressions (0-2 points), verbal reaction (0-2 points), position of the body (1-2 points), touch (1-2 points), and position of the legs (1-2 points). Minimum score is 4 (no pain) and maximum is 13 (maximum pain). Grades are summed together. CHEOPS has a minimum possible score of 4 points (no pain) to a maximum of 13 points (the worst pain).

    When the postoperative pain score exceeded four, rescue analgesia was given with a 20mg/kg paracetamol suppository.

    Measured: for 6 hours after surgery

Secondary outcomes (3)
  1. Time to first analgesic request

    Time to first analgesic request

    Measured: during first 24 hours

  2. number of patients requiring rescue analgesic

    Measured: during first 24 hours

  3. incidence of postoperative nausea and vomiting

    Measured: during first 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2018
  2. Study start20 Aug 2018
  3. Primary completion20 Oct 2018
  4. Study completion1 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03640598
Sponsor's protocol ID
R.18.05.202
Status last verified
Mar 2019
First submitted
18 Aug 2018
Last updated
27 Mar 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Ilioinguinal/iliohypogastric nerve blocks and Erector spinae nerve block in people with Inguinal Hernia, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative CHEOPS scale (time frame: for 6 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in